Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Sheen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
PNAS Nexus|January 30, 2023
Intratumoral nanobody-IL-2 fusions that bind the tumor extracellular matrix suppress solid tumor growth in miceEmi A Lutz, Noor Jailkhani, Noor Momin, et al.
Mabs|August 4, 2022
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapySarah C Cowles, Allison Sheen, Luciano Santollani, et al.
Redox Biology|June 13, 2023
Tumor-localized catalases can fail to alter tumor growth and transcriptional profiles in subcutaneous syngeneic mouse tumor modelsAllison Sheen, Yash Agarwal, Keith M Cheah, et al.
Molecular Cancer Therapeutics|October 9, 2024
Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor ControlJordan A Stinson, Allison Sheen, Brianna M Lax, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue SarcomasJordan A Stinson, Allison Sheen, Noor Momin, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogsJordan A Stinson, Matheus Moreno P Barbosa, Allison Sheen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2024
Tumor-Localized Interleukin-2 and Interleukin-12 Combine with Radiation Therapy to Safely Potentiate Regression of Advanced Malignant Melanoma in Pet DogsJordan A Stinson, Matheus Moreno P Barbosa, Allison Sheen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2023
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodiesBrianna M Lax, Joseph R Palmeri, Emi A Lutz, et al.
JCI Insight|September 5, 2023
Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2Brendan L Horton, Alicia D D'Souza, Maria Zagorulya, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapiesEmi A Lutz, Yash Agarwal, Noor Momin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
PNAS Nexus|January 30, 2023
Intratumoral nanobody-IL-2 fusions that bind the tumor extracellular matrix suppress solid tumor growth in miceEmi A Lutz, Noor Jailkhani, Noor Momin, et al.
Mabs|August 4, 2022
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapySarah C Cowles, Allison Sheen, Luciano Santollani, et al.
Redox Biology|June 13, 2023
Tumor-localized catalases can fail to alter tumor growth and transcriptional profiles in subcutaneous syngeneic mouse tumor modelsAllison Sheen, Yash Agarwal, Keith M Cheah, et al.
Molecular Cancer Therapeutics|October 9, 2024
Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor ControlJordan A Stinson, Allison Sheen, Brianna M Lax, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue SarcomasJordan A Stinson, Allison Sheen, Noor Momin, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogsJordan A Stinson, Matheus Moreno P Barbosa, Allison Sheen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2024
Tumor-Localized Interleukin-2 and Interleukin-12 Combine with Radiation Therapy to Safely Potentiate Regression of Advanced Malignant Melanoma in Pet DogsJordan A Stinson, Matheus Moreno P Barbosa, Allison Sheen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2023
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodiesBrianna M Lax, Joseph R Palmeri, Emi A Lutz, et al.
JCI Insight|September 5, 2023
Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2Brendan L Horton, Alicia D D'Souza, Maria Zagorulya, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapiesEmi A Lutz, Yash Agarwal, Noor Momin, et al.
Pageof 2